SEC FORM 4
$599,509.50
Mirum Pharmaceuticals, Inc. (MIRM)
Sale of 6,001 shares at $99.9016 per share.
Reporting Person BJERKHOLT ERIC · Officer Title CHIEF FINANCIAL OFFICER · Transaction Code S
Traded Aug 11, 2026 · Disclosed Aug 12, 2026
Source: SEC Form 4 · 0001197350-26-000009 · filed 2026-08-12 · View filing →